(redirected from Topical drug)
Also found in: Dictionary, Thesaurus, Medical, Encyclopedia.
Related to Topical drug: topically, Topical application, topical administration
References in periodicals archive ?
Trends in topical drug delivery dealmaking in the biopharma industry since 2010
Topical Drug Delivery Partnering 2010-2015 report provides understanding and access to the topical drug delivery partnering deals and agreements entered into by the world's leading healthcare companies.
Swiedler, MD, PhD, BioMarin's vice president, Scientific and Clinical Affairs, said, "Vibriolysin Topical's unique propensity for selectively breaking down dead tissue without digesting healthy tissue, as demonstrated in preclinical studies, suggests that Vibriolysin Topical may offer physicians treating burns a safe and effective alternative to surgery and other less effective topical drugs for the debridement of burn wounds.
TetraStem is a topical liquid tetracycline-based antibiotic that uses a patent-pending innovative transdermal delivery system that can convert oral medication active ingredients into topical drugs.
announced today that it has received regulatory approval to initiate a Phase Ia clinical trial in Canada with CTA018, a topical drug for the treatment of mild to moderate psoriasis.
6 million for the development of a topical drug candidate for atopic dermatitis.
Practical and effective approaches to topical drug development will be covered including:
The mission of the Imprimis Science and Regulatory Advisory Board will be to advise Imprimis management on the future development of the patented Accudel topical drug delivery platform and to assist in the design and execution of the planned Phase 3 clinical studies for Imprimis's topical 10% ketoprofen anti-inflammatory drug called Impracor.
Natroba is a topical drug product and should be applied only to the child's scalp or hair.
Under the agreement, IGI will be responsible for developing two topical drug products, obtaining FDA marketing approvals, and manufacturing the commercial products for Impax.
rights to manufacture, market and sell the antiviral topical drug Denavir owned by Novartis.
Chris Mengler, president of Global Pharmaceuticals, said: "We look forward to working with the experienced team at IGI Laboratories on these two topical drug products.